Mark Orr
About Mark Orr
Mark Orr is a Senior Principal Scientist specializing in Immuno-Oncology and Cellular Therapy at Bristol Myers Squibb and an Affiliate Assistant Professor at the University of Washington. He has a strong background in immunology and has advanced multiple products from conception to clinical use.
Title
Mark Orr currently holds the position of Senior Principal Scientist, Immuno-Oncology and Cellular Therapy at Bristol Myers Squibb in Seattle, Washington, United States.
Company
Mark Orr is employed by Bristol Myers Squibb, where he works on Immuno-Oncology and Cellular Therapy. His role involves developing treatments for serious diseases through research and development of biopharmaceuticals.
Education and Expertise
Mark Orr earned his PhD in Immunology from the University of Washington - School of Medicine, where he studied from 2000 to 2006. He also holds a B.S. in ACS Chemistry from Tennessee Technological University, achieved between 1995 and 2000. His expertise spans innate and adaptive immune mechanisms, focusing on host and engineered responses to infections and malignancies.
Background
Before his current role, Mark Orr accumulated a wealth of experience in various scientific and leadership roles. He worked as Principal Scientist, Translational Sciences at Bristol Myers Squibb from 2019 to 2021. At Celgene, he was Principal Scientist, Translational Sciences in 2019. He also served as Vice President, Immunology at HDT Bio Corp from 2018 to 2019 and held multiple positions at the Infectious Disease Research Institute from 2010 to 2019, culminating in Senior Scientist, Vaccine Development. Earlier in his career, he was a Postdoctoral Fellow in Immunology at the University of California, San Francisco.
Achievements
Mark Orr has successfully advanced multiple products from conception to clinical utilization. He has a significant role in developing innovative treatments for serious diseases, particularly in the field of Immuno-Oncology and Cellular Therapy. His work often focuses on translational medicine to bridge the gap between laboratory research and patient care, utilizing data analytics to enhance therapeutic precision. He also contributes academically as an Affiliate Assistant Professor at the University of Washington, Department of Global Health.